NAS:MLTX (Switzerland)
Â
Class A
$
39.84
+1.45 (+3.78%)
12:08 AM EST
What is a stock summary page? Click here for an overview.
Business Description
MoonLake Immunotherapeutics
NAICS : 541720
SIC : 2833
ISIN : KY61559X1045
Share Class Description:
MLTX: Class ADescription
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 158.31 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | -25.64 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.57 | |||||
| 9-Day RSI | 50.36 | |||||
| 14-Day RSI | 47.32 | |||||
| 3-1 Month Momentum % | -24.56 | |||||
| 6-1 Month Momentum % | -15.45 | |||||
| 12-1 Month Momentum % | -16.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 21.11 | |||||
| Quick Ratio | 21.11 | |||||
| Cash Ratio | 19.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.5 | |||||
| Shareholder Yield % | -2.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -23.85 | |||||
| ROA % | -22.6 | |||||
| ROIC % | -1037.96 | |||||
| ROC (Joel Greenblatt) % | -2723.14 | |||||
| ROCE % | -27.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5.62 | |||||
| Price-to-Tangible-Book | 5.63 | |||||
| EV-to-EBIT | -13.91 | |||||
| EV-to-EBITDA | -14.05 | |||||
| EV-to-Forward-Revenue | 30.21 | |||||
| EV-to-FCF | -17 | |||||
| Price-to-Net-Current-Asset-Value | 5.67 | |||||
| Price-to-Net-Cash | 6.03 | |||||
| Earnings Yield (Greenblatt) % | -7.19 | |||||
| FCF Yield % | -4.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MLTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MoonLake Immunotherapeutics Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.89 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 38.18 | ||
| 14-Day RSI | 47.32 | ||
| 14-Day ATR ($) | 1.930117 | ||
| 20-Day SMA ($) | 39.3655 | ||
| 12-1 Month Momentum % | -16.81 | ||
| 52-Week Range ($) | 36.52 - 58.26 | ||
| Shares Outstanding (Mil) | 63.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MoonLake Immunotherapeutics Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MoonLake Immunotherapeutics Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MoonLake Immunotherapeutics Frequently Asked Questions
What is MoonLake Immunotherapeutics(MLTX)'s stock price today?
The current price of MLTX is $39.84. The 52 week high of MLTX is $58.26 and 52 week low is $36.52.
When is next earnings date of MoonLake Immunotherapeutics(MLTX)?
The next earnings date of MoonLake Immunotherapeutics(MLTX) is 2025-05-07 Est..
Does MoonLake Immunotherapeutics(MLTX) pay dividends? If so, how much?
MoonLake Immunotherapeutics(MLTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers